| scholarly article | Q13442814 |
| P2093 | author name string | H-J Kung | |
| L Xue | |||
| R W deVere White | |||
| R Gandour-Edwards | |||
| C G Tepper | |||
| X-B Shi | |||
| A-H Ma | |||
| P2860 | cites work | Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors | Q24337932 |
| A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
| Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 | ||
| The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing | Q24631683 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| miR-34a repression of SIRT1 regulates apoptosis | Q24652720 | ||
| Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 | ||
| A functional study of miR-124 in the developing neural tube | Q24680783 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
| Molecular determinants of resistance to antiandrogen therapy | Q28236889 | ||
| Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths | Q28241157 | ||
| mir-17-92, a cluster of miRNAs in the midst of the cancer network | Q28275929 | ||
| Genetic unmasking of an epigenetically silenced microRNA in human cancer cells | Q28288806 | ||
| Small molecule inhibitors targeting the "achilles' heel" of androgen receptor activity | Q33810134 | ||
| Cyclin-dependent kinase 6 associates with the androgen receptor and enhances its transcriptional activity in prostate cancer cells | Q33936048 | ||
| Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro | Q33946560 | ||
| Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma | Q34031613 | ||
| Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells | Q34166215 | ||
| Expression and role of Foxa proteins in prostate cancer | Q34650779 | ||
| Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially. | Q34651730 | ||
| Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma | Q34778280 | ||
| miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma | Q35008738 | ||
| Regulation of MicroRNA Biogenesis: A miRiad of mechanisms | Q35575239 | ||
| An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells | Q36288990 | ||
| MicroRNA function in cancer: oncogene or a tumor suppressor? | Q37655612 | ||
| A survey of gene-specific methylation in human prostate cancer among black and white men. | Q38448433 | ||
| Identification of p53 mutations in archival prostate tumors. Sensitivity of an optimized single-strand conformational polymorphism (SSCP) assay | Q38476615 | ||
| miR‐125b promotes growth of prostate cancer xenograft tumor through targeting pro‐apoptotic genes | Q39649207 | ||
| miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer. | Q39752124 | ||
| Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia | Q39852549 | ||
| MicroRNA-125b is a novel negative regulator of p53. | Q39871732 | ||
| DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect | Q39891532 | ||
| DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines | Q40033345 | ||
| MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines | Q40140488 | ||
| HMGA1 inhibits the function of p53 family members in thyroid cancer cells. | Q40304192 | ||
| High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity. | Q40341382 | ||
| Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line | Q40689267 | ||
| Methylation of the CD44 metastasis suppressor gene in human prostate cancer | Q40951822 | ||
| Loss of two new loci on chromosome 8 (8p23 and 8q12-13) in human prostate cancer | Q41607956 | ||
| MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells | Q42808496 | ||
| Molecular alterations associated with LNCaP cell progression to androgen independence | Q44920059 | ||
| Human androgen receptor expression in prostate cancer following androgen ablation | Q46097214 | ||
| Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia | Q47242342 | ||
| Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats | Q71804683 | ||
| E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas | Q71804951 | ||
| Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization | Q72559577 | ||
| Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer | Q72989706 | ||
| High mobility group protein I(Y): a candidate architectural protein for chromosomal rearrangements in prostate cancer cells | Q77601972 | ||
| Clinical significance of chromosome 8p, 10q, and 16q deletions in prostate cancer | Q78705329 | ||
| Integration of somatic deletion analysis of prostate cancers and germline linkage analysis of prostate cancer families reveals two small consensus regions for prostate cancer genes at 8p | Q80274311 | ||
| MicroRNAs and prostate cancer | Q81636363 | ||
| P433 | issue | 35 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 4130-4138 | |
| P577 | publication date | 2012-10-15 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells | |
| P478 | volume | 32 |
| Q28573536 | A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells |
| Q33641704 | A networks method for ranking microRNA dysregulation in cancer. |
| Q34689139 | Acetylcholine acts on androgen receptor to promote the migration and invasion but inhibit the apoptosis of human hepatocarcinoma |
| Q26795625 | Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer |
| Q64102031 | Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth |
| Q35802733 | Association of the pri-miR-124-1 rs531564 polymorphism with cancer risk: A meta-analysis |
| Q38931043 | BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence |
| Q89511631 | Cationic Polymer Nanoparticles-Mediated Delivery of miR-124 Impairs Tumorigenicity of Prostate Cancer Cells |
| Q34714581 | Characterization of human plasma-derived exosomal RNAs by deep sequencing. |
| Q92153845 | Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide |
| Q33766123 | Circular RNAs: Biogenesis, Function and Role in Human Diseases. |
| Q90651960 | Comprehensive Assessment of the Relationship Between MicroRNA-124 and the Prognostic Significance of Cancer |
| Q34628905 | Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7 |
| Q35601474 | Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer |
| Q39285589 | Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives. |
| Q42040180 | Down-regulation of RE-1 silencing transcription factor (REST) in advanced prostate cancer by hypoxia-induced miR-106b~25. |
| Q37309826 | Epigenetic silencing of miR-124 prevents spermine oxidase regulation: implications for Helicobacter pylori-induced gastric cancer. |
| Q37629548 | Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy |
| Q35552855 | Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer. |
| Q38902049 | Gap Junctions Enhance the Antiproliferative Effect of MicroRNA-124-3p in Glioblastoma Cells |
| Q37328606 | Genetic Variations in Key MicroRNAs are Associated With the Survival of Nonsmall Cell Lung Cancer |
| Q37483696 | Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells |
| Q38785225 | Hypoxia-responsive miR-124 and miR-144 reduce hypoxia-induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1. |
| Q33564556 | ISMARA: automated modeling of genomic signals as a democracy of regulatory motifs |
| Q36147506 | Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening |
| Q38879139 | Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals |
| Q92323764 | Interfering cellular lactate homeostasis overcomes Taxol resistance of breast cancer cells through the microRNA-124-mediated lactate transporter (MCT1) inhibition |
| Q38160108 | Interplay between microRNAs and the STAT3 signaling pathway in human cancers |
| Q50234048 | Interrelation of androgen receptor and miR-30a and miR-30a function in ER-, PR-, AR+ MDA-MB-453 breast cancer cells |
| Q35618570 | KITENIN-targeting microRNA-124 suppresses colorectal cancer cell motility and tumorigenesis |
| Q37295572 | Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3. |
| Q38721848 | MiR-124 down-regulation is critical for cancer associated fibroblasts-enhanced tumor growth of oral carcinoma |
| Q37427776 | MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1. |
| Q38303354 | MiR-124 retards bladder cancer growth by directly targeting CDK4. |
| Q37170170 | MiR-124-3p/B4GALT1 axis plays an important role in SOCS3-regulated growth and chemo-sensitivity of CML. |
| Q99712011 | MiR-124a Regulates Extracellular Vesicle Release by Targeting GTPase Rabs in Lung Cancer |
| Q38937055 | Micro RNAs: an arguable appraisal in medicine. |
| Q28817827 | MicroRNA-124 enhances response to radiotherapy in human epidermal growth factor receptor 2-positive breast cancer cells by targeting signal transducer and activator of transcription 3 |
| Q43131716 | MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma |
| Q39012739 | MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer |
| Q37413876 | MicroRNA-124 promotes hepatic triglyceride accumulation through targeting tribbles homolog 3. |
| Q52649693 | MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study. |
| Q92467659 | MicroRNA-124: An emerging therapeutic target in cancer |
| Q38838196 | MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells |
| Q35522595 | MicroRNA-mediated regulation of p21 and TASK1 cellular restriction factors enhances HIV-1 infection |
| Q38205266 | MicroRNAs and drug resistance in prostate cancers |
| Q27008271 | MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans |
| Q92307066 | MicroRNA‑124 negatively regulates chloride intracellular channel 1 to suppress the migration and invasion of liver cancer cells |
| Q33643578 | Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer |
| Q26774456 | Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism |
| Q38667234 | Non-coding RNAs in Prostate Cancer: From Discovery to Clinical Applications |
| Q49530055 | Oxibendazole inhibits prostate cancer cell growth |
| Q36109708 | Pri-miR-124 rs531564 polymorphism and colorectal cancer risk |
| Q58786195 | Profiling and bioinformatics analyses of differential circular RNA expression in prostate cancer cells |
| Q38693627 | Pyrosequencing quantified methylation level of miR-124 predicts shorter survival for patients with myelodysplastic syndrome |
| Q35363913 | Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells |
| Q33817108 | Retracted: The Tumor Suppressor Role of miR-124 in Osteosarcoma |
| Q36844904 | Role of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience |
| Q47151099 | Role of miR-124a in T cell activation and immunity in AIDS patients |
| Q38086009 | Roles of microRNAs during prostatic tumorigenesis and tumor progression |
| Q35619400 | STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells |
| Q36685517 | Screening key microRNAs for castration-resistant prostate cancer based on miRNA/mRNA functional synergistic network |
| Q40615429 | Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma |
| Q39044222 | Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine. |
| Q49451471 | Systematic analysis of the molecular mechanism of microRNA-124 in hepatoblastoma cells |
| Q38109474 | The genomic landscape of prostate cancer |
| Q36002634 | The inhibitory effects of AR/miR-190a/YB-1 negative feedback loop on prostate cancer and underlying mechanism |
| Q47669687 | The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies |
| Q92942425 | The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma |
| Q38220789 | The role of microRNA in castration-resistant prostate cancer |
| Q38819163 | miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src. |
| Q39052473 | miR-124 functions as a tumor suppressor in the endometrial carcinoma cell line HEC-1B partly by suppressing STAT3. |
| Q39017343 | miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer |
| Q39220695 | miRNA in Prostate Cancer: New Prospects for Old Challenges |
| Q48224625 | microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11. |
| Q34920251 | microRNA-124 inhibits migration and invasion by down-regulating ROCK1 in glioma |
Search more.